Gennex Laboratories Ltd Financial Ratios
GENNEX · Healthcare · Current price ₹9.1
P/E ratio
12.0x
P/B ratio
1.2x
ROE
8.3%
ROCE
10.6%
Debt / Equity
0.16
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 12.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 8.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 10.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.16 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Gennex Laboratories Ltd's latest numbers.
Gennex Laboratories Ltd profitability
Gennex Laboratories Ltd generates a return on equity of 8.3% and a return on capital employed of 10.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.16 and a P/E of 12.0x, Gennex Laboratories Ltd is conservatively financed. Our overall business-quality score for the company is 4.6 / 10.
Understand the ratios
More on Gennex Laboratories Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.